A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice
Laura Lazo(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Ronen Tchelet(Start International), Ania Cabrales(Centro de Ingeniería Genética y Biotecnología), Mark Emalfarb(Start International), Gilda Lemos(Centro de Ingeniería Genética y Biotecnología), Andy Bruno(Centro de Ingeniería Genética y Biotecnología), Luis Ariel Espinosa(Centro de Ingeniería Genética y Biotecnología), Amalia Dávila Hernández(Centro de Ingeniería Genética y Biotecnología), Alexis Musacchio(Instituto Cajal), Marika Vitikainen(VTT Technical Research Centre of Finland), Markku Saloheimo(VTT Technical Research Centre of Finland), Mónica Béquet‐Romero(Centro de Ingeniería Genética y Biotecnología)
Cited by 21
Related Papers
Genome sequencing and analysis of the biomass-degrading fungus Trichoderma reesei (syn. Hypocrea jecorina)
|Nature Biotechnology|2008|1.3k
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139